MVision’s Guideline-Based AI Segmentation is Available in the EduCase Platform

Helsinki – 19th of January, 2022 – MVision AI, the leading provider of the guideline-based solution, collaborates with EduCase, the global leader in web-based education designed to support contouring skill instructions for radiation oncologists. EduCase is a computer-based training tool developed by RadOnc eLearning Center, LLC., to assist the development of structure segmentation (contouring) skills of radiation oncologists, medical physicists, and dosimetrists. 

The educational collaboration entitles EduCase to include MVision’s guideline-compliant AI segmentation, GCAIS™, software in all teaching sessions. This supplements students with hands-on experience working with MVision’s state-of-the-art solution. The MVisionaries will support EduCase to help educate the students, providing them with the unique opportunity to work with our groundbreaking AI models. 

“We are excited to be working with and delivering this new EdTech feature by integrating MVision’s AI segmentation guideline structures into the EduCase contour training platform. We are seeing significant demand in AI training in radiotherapy, and its impact and influence on the  educational ecosystem of Radiation Oncology, Contouring, and Education.” said Scott Kaylor: Co-Founder of EduCase

“Advancements of AI in Radiotherapy are redefining the role of clinicians. Education and training are becoming essential for clinicians to deliver high-quality treatment. Through our collaboration with EduCase, MVision is very excited to bring AI models to the EduCase platform to further accelerate the adoption of this novel technology” said Mahmudul Hasan: Co-Founder and CEO of MVision AI 

Discover EduCase

Website: https://www.educase.com/ 

LinkedIn: https://www.linkedin.com/company/radonc-elearning-center-inc./ 

Are you eager to explore GCAIS™? Request a demo here. 

MVision AI is active on LinkedIn, Twitter, Facebook, and Instagram. Follow us on social media and subscribe to our newsletter to stay up-to-date on the latest MVision AI news.

Welcome you to contact MVision AI:

c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland.

Tel: +358 (0) 40 5489 229

Website: https://www.mvision.ai 

Email: info@mvision.ai 

For media inquiries:

Tel: +358 40 500 7915

Email: pr@mvision.ai

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

20.6.2024

World Kidney Cancer Day 2024: “Listen”

World Kidney Cancer Day is observed every year on the second Thursday of June. “Listening” is this year’s theme, which refers to the benefits of shared decision making, patient’s empowerment to seek a second opinion and creating awareness around misinformation and how to check if sources are reliable (1). More…

News

14.6.2024

MVision AI Appoints Antti Pirskanen as New Chief Financial Officer

Helsinki, Finland – June 14, 2024 – MVision AI, a pioneering company in the development of innovative AI solutions for radiation oncology is pleased to announce the appointment of Antti Pirskanen as its new Chief Financial Officer (CFO). Antti will assume his responsibilities immediately, bringing extensive expertise in financial management…

Press Releases

14.6.2024

MVision AI Receives MFDS Approval and Market Authorization for South Korea

HELSINKI, Finland – June 14, 2024 MVision AI is pleased to announce that our application for MVision AI Segmentation (Contour+) in South Korea has been accepted by the Ministry of Food and Drug Safety (MFDS) under the “Image Segmentation Application Software” for image analysis algorithms to be used in radiation…

Press Releases